Redsense offsets loan raised in connection with directed share issue
The Board of Directors of Redsense Medical AB (publ.) has resolved, in accordance with the authorization given by the Annual General Meeting on 6 May 2019, to increase the Company’s share capital with SEK 30,514.90 through a directed new share issue.The new share issue is directed to Gerhard Dal and Modelio Equity AB. The share price is set to SEK 10.38 under the agreement, which corresponds to a 10 percent discount compared to the volume-weightedaverage priceduring the period between 2019-10-09 and 2019-10-29. The amount of the loan offset by the issue is MSEK 3 plus interest. As the